{"title": "Cristina Fornaguera Puigvert, PhD - IQS", "author": null, "url": "https://techtransfer.iqs.edu/en/people/cristina-fornaguera-puigvert-phd/", "hostname": "techtransfer.iqs.edu", "description": "IQS Tech Transfer", "sitename": "IQS Tech Transfer", "date": "2021-10-25", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Cristina Fornaguera Puigvert, PhD\nAssociate Professor\n+34932672000\nRESEARCH LINES\n- Polymeric nanosystems for biomedical applications.\n- Design of advanced drug delivery systems.\n- Design of non-viral vectors for gene therapy.\n- Optimisation of nanoformulations with organ-specific vectorisation.\n- Formulation of mRNA vaccines based on nanosystems.\n- Design of new immunotherapies for cancer treatment\nMEMBER OF:\nSchool of Engineering\nMaterials Engineering\nIts activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.\nLATEST PROJECTS\nDemiRNApy (Role of miRNAs in the anterior cingulate cortex, as peripheral biomarkers, and their targeted modulation by nano-tools as a antidepressant therapy)\nRole of microRNAs in the brain , as peripheral biomarkers and as nano-tools as novel antidepressant therapy\nFunding Agency:\nResearch Group Link:\nMaterials Engineering (GEMAT)\nTumorOut (Innovative mRNA vaccine against lung cancer)\nInnovative platform of targeted polymeric nanoparticles for efficient personalized therapy against lung cancer\nFunding Agency:\nResearch Group Link:\nMaterials Engineering (GEMAT)\nZwiRNA (Nanopart\u00edculas zwiteri\u00f3nicas como vacunas de ARNm contra el c\u00e1ncer pulmonar)\nDesarrollo de Nanopart\u00edculas zwiteri\u00f3nicas de Poli(beta-aminoester) como vacunas de mRNA para tratar el c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as (zwiRNA).\nFunding Agency:\nResearch Group Link:\nMaterials Engineering (GEMAT)\nLINKED NEWS\nResearch\nNew personalized therapeutic vaccine for lung cancer\n07/03/2023\nIQS professor Dr Cristina Fornaguera is leading the European project TumorOUT to design a new immunotherapy based on polymer nanoparticles with encapsulated antigenic mRNAs to holistically attack different mechanisms of lung cancer.\n[READ FULL NEW](https://techtransfer.iqs.edu/en/news/new-personalized-therapeutic-vaccine-for-lung-cancer/)\nResearch\nMicro RNAs to Treat Depression\n09/01/2023\nIQS is one of the members of the DemiRNApy project, one of the 36 research projects selected by the Fundaci\u00f3 Marat\u00f3 TV3 charitable fundraising drive in its 2021 edition dedicated to mental health, with the aim of developing nanotherapies to treat depression.\n[READ FULL NEW](https://techtransfer.iqs.edu/en/news/micro-rnas-to-treat-depression/)\nResearch\nInvisible, Targeted mRNA Vaccines\n03/11/2022\nThe GEMAT group at IQS is working on the zwiRNA project with the goal of designing a new state-of-the-art therapeutic vaccine for the treatment of lung cancer.\n[READ FULL NEW](https://techtransfer.iqs.edu/en/news/invisible-targeted-mrna-vaccines/)\nInterview\nInterview with Dr Jos\u00e9 Rodrigo Maga\u00f1a and Dr Cristina Fornaguera\n10/06/2022\n\"My contribution to the ANTIEMT project is designing genetic material transporters. They are invisible polymers for most of the body's cells, except for tumor cells, to which they are targeted as \u2018ninjas.\u2019\"\n[READ FULL NEW](https://techtransfer.iqs.edu/en/news/interview-with-dr-jose-rodrigo-magana-and-dr-cristina-fornaguera/)\nNews\nConfocal Microscopy\n05/02/2021\nIQS has a Leica SP8 Confocal Scanning Microscope used for any application that involves the analysis of images that emit fluorescence, on their own or if they have been previously labeled with fluorophores, that allows the analysis of materials and biomaterials in addition to the analysis of biological tissues and cell culture.\n[READ FULL NEW](https://techtransfer.iqs.edu/en/news/confocal-microscopy/)\nInterview\nDr Borr\u00f3s and Dr Fornaguera, leaders of the CoviNanoVax project\n08/01/2021\n\u201cWe have our mRNA encapsulated, which appears from the outset that it will be immunogenic, stable and non-toxic, with stable nanoparticles at 4\u00baC, and obtained through an easily scalable process.\u201c\n[READ FULL NEW](https://techtransfer.iqs.edu/en/news/dr-borros-and-dr-fornaguera-leaders-of-the-covinanovax-project/) [](javascript:;)", "language": null, "image": "https://techtransfer.iqs.edu/wp-content/uploads/2021/10/iqs-fornaguera-cristina-2021-001-sq-scaled.jpg", "pagetype": "article", "links": ["https://techtransfer.iqs.edu/en/accreditations-and-certifications/", "https://techtransfer.iqs.edu/en/location/", "https://techtransfer.iqs.edu/en/", "javascript:;", "https://techtransfer.iqs.edu/en/about-us/", "https://techtransfer.iqs.edu/en/about-us/", "https://techtransfer.iqs.edu/en/our-team/", "https://techtransfer.iqs.edu/en/research-groups/", "https://techtransfer.iqs.edu/en/facilities/", "https://techtransfer.iqs.edu/en/partners/", "https://techtransfer.iqs.edu/en/location/", "https://techtransfer.iqs.edu/en/research-projects/", "https://techtransfer.iqs.edu/en/solutions-for-companies/", "https://techtransfer.iqs.edu/en/news/", "https://techtransfer.iqs.edu/personas/dra-cristina-fornaguera-puigvert/", "https://techtransfer.iqs.edu/ca/persones/dra-cristina-fornaguera-puigvert/", "https://techtransfer.iqs.edu/en/people/cristina-fornaguera-puigvert-phd/", "https://techtransfer.iqs.edu", "https://techtransfer.iqs.edu/en/about-us/", "https://techtransfer.iqs.edu/en/our-team/", "mailto:cristina.fornaguera@iqs.url.edu", "https://www.iqs.edu/en/dra-cristina-fornaguera-i-puigvert", "https://orcid.org/0000000270143213", "https://techtransfer.iqs.edu/en/groups/materials-engineering-gemat/", "https://techtransfer.iqs.edu/en/projects/demirnapy-role-of-mirnas-in-the-anterior-cingulate-cortex-as-peripheral-biomarkers-and-their-targeted-modulation-by-nano-tools-as-a-antidepressant-therapy/", "https://techtransfer.iqs.edu/en/projects/tumorout-innovative-mrna-vaccine-against-lung-cancer/", "https://techtransfer.iqs.edu/en/projects/zwirna-nanoparticulas-zwiterionicas-como-vacunas-de-arnm-contra-el-cancer-pulmonar/", "https://techtransfer.iqs.edu/en/projects/gard-lafora-use-of-mrna-loaded-polymeric-nanoparticles-as-an-innovative-replacement-therapy-to-treat-lafora-disease/", "https://techtransfer.iqs.edu/en/projects/livenano-nuevas-nanoterapias-industrialmente-escalables-para-tratar-la-hipertension-portal-y-la-fibrosis-hepatica-en-humanos/", "https://techtransfer.iqs.edu/en/projects/adc2gbm-nano-farmacos-terapeuticos-permeables-a-la-barrera-hematoencefalica-contra-las-celulas-madre-del-glioma/", "https://techtransfer.iqs.edu/en/projects/nanoparticulas-con-micro-arn-para-inhibir-celulas-cancerosas-mesenquimales/", "https://techtransfer.iqs.edu/en/projects/covinanovax/", "javascript:;", "javascript:;", "javascript:;", "https://techtransfer.iqs.edu/en/research-projects/", "https://techtransfer.iqs.edu/en/news/new-personalized-therapeutic-vaccine-for-lung-cancer/", "https://techtransfer.iqs.edu/en/news/new-personalized-therapeutic-vaccine-for-lung-cancer/", "https://techtransfer.iqs.edu/en/news/new-personalized-therapeutic-vaccine-for-lung-cancer/", "https://techtransfer.iqs.edu/en/news/micro-rnas-to-treat-depression/", "https://techtransfer.iqs.edu/en/news/micro-rnas-to-treat-depression/", "https://techtransfer.iqs.edu/en/news/micro-rnas-to-treat-depression/", "https://techtransfer.iqs.edu/en/news/invisible-targeted-mrna-vaccines/", "https://techtransfer.iqs.edu/en/news/invisible-targeted-mrna-vaccines/", "https://techtransfer.iqs.edu/en/news/invisible-targeted-mrna-vaccines/", "https://techtransfer.iqs.edu/en/news/interview-with-dr-jose-rodrigo-magana-and-dr-cristina-fornaguera/", "https://techtransfer.iqs.edu/en/news/interview-with-dr-jose-rodrigo-magana-and-dr-cristina-fornaguera/", "https://techtransfer.iqs.edu/en/news/interview-with-dr-jose-rodrigo-magana-and-dr-cristina-fornaguera/", "https://techtransfer.iqs.edu/en/news/confocal-microscopy/", "https://techtransfer.iqs.edu/en/news/confocal-microscopy/", "https://techtransfer.iqs.edu/en/news/confocal-microscopy/", "https://techtransfer.iqs.edu/en/news/dr-borros-and-dr-fornaguera-leaders-of-the-covinanovax-project/", "https://techtransfer.iqs.edu/en/news/dr-borros-and-dr-fornaguera-leaders-of-the-covinanovax-project/", "https://techtransfer.iqs.edu/en/news/dr-borros-and-dr-fornaguera-leaders-of-the-covinanovax-project/", "https://techtransfer.iqs.edu/en/news/", "https://techtransfer.iqs.edu/", "https://techtransfer.iqs.edu/en/", "https://techtransfer.iqs.edu/en/about-us/", "https://techtransfer.iqs.edu/en/research-projects/", "https://techtransfer.iqs.edu/en/solutions-for-companies/", "https://techtransfer.iqs.edu/en/news/", "https://techtransfer.iqs.edu/en/location/", "https://techtransfer.iqs.edu/en/accreditations-and-certifications/", "https://techtransfer.iqs.edu/en/cookie-policy/", "https://techtransfer.iqs.edu/en/privacy-policy/", "javascript:;", "/politica-de-privacidad/", null, null, null, null, null, null]}